Cell MedX Corp. (CMXC)
USD 0.43
(0.0%)
USD 0.43
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -145.89 Thousand | -272.2 Thousand | -450.59 Thousand | -560.43 Thousand | -925.84 Thousand | -307.54 Thousand |
| Net Income | -142.48 Thousand | -495.04 Thousand | -697.37 Thousand | -910.83 Thousand | -1.09 Million | -905.98 Thousand |
| Depreciation & Amortization | - | - | 1145.00 | 2434.00 | 1846.00 | 580.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 116.07 Thousand | 104.3 Thousand | 137.97 Thousand | 220.39 Thousand | 17.99 Thousand | 356.71 Thousand |
| Other non-cash items | -166.23 Thousand | 118.52 Thousand | 107.66 Thousand | 127.57 Thousand | 147.01 Thousand | 241.14 Thousand |
| Investing Cash Flow | - | - | - | -1574.00 | -2463.00 | -1915.00 |
| Investments in PPE | -2.00 | - | - | -1574.00 | -2463.00 | -1915.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -1574.00 | - | -1915.00 |
| Financing Cash Flow | 91.03 Thousand | 346.36 Thousand | 453.97 Thousand | 535.09 Thousand | 916.42 Thousand | 359.12 Thousand |
| Debt repayment | -16.03 Thousand | -346.36 Thousand | -293.97 Thousand | -328.09 Thousand | -327.65 Thousand | -297 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 75 Thousand | - | 160 Thousand | 207 Thousand | 486 Thousand | - |
| Other Financing Activities | 75 Thousand | 346.36 Thousand | 453.97 Thousand | 656.19 Thousand | 758.07 Thousand | 656.12 Thousand |
| Accounts receivables | - | - | - | - | 8822.00 | - |
| Accounts payables | 46.75 Thousand | -14.06 Thousand | 19.95 Thousand | 54.08 Thousand | 46.57 Thousand | 141.58 Thousand |
| Inventory | - | - | - | 12.71 Thousand | 20.5 Thousand | -64.31 Thousand |
| Other working capital | 69.32 Thousand | 14.06 Thousand | 118.02 Thousand | 153.59 Thousand | -57.9 Thousand | 279.43 Thousand |
| Cash at beginning of period | 98.29 Thousand | 24.38 Thousand | 20.75 Thousand | 45.09 Thousand | 57.17 Thousand | 8200.00 |
| Cash at end of period | 43.41 Thousand | 98.29 Thousand | 24.38 Thousand | 20.75 Thousand | 45.09 Thousand | 57.17 Thousand |
| Capital Expenditure | -2.00 | - | - | -1574.00 | -2463.00 | -1915.00 |
| Effect of forex changes on cash | -15.00 | -240.00 | 247.00 | 2573.00 | -197.00 | -696.00 |
| Net cash flow / Change in cash | -54.88 Thousand | 73.91 Thousand | 3627.00 | -24.33 Thousand | -12.08 Thousand | 48.97 Thousand |
| Free Cash Flow | -145.9 Thousand | -272.2 Thousand | -450.59 Thousand | -562 Thousand | -928.3 Thousand | -309.45 Thousand |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -142.48 Thousand | -124.95 Thousand | 119.97 Thousand | -60.54 Thousand | -76.95 Thousand | -79.38 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 116.07 Thousand | 76.78 Thousand | 20.49 Thousand | 1199.00 | 16.1 Thousand | 39.08 Thousand |
| Other non-cash items | -166.23 Thousand | 6660.00 | -178.4 Thousand | 24.02 Thousand | 20.49 Thousand | 14.67 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | -3.34 | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 91.03 Thousand | -5268.25 | 95 Thousand | - | - | 116.37 Thousand |
| Debt repayment | -16.03 Thousand | -4202.46 | -20.03 Thousand | - | - | -117.69 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 75 Thousand | -1065.79 | 75.14 Thousand | - | - | - |
| Other Financing Activities | 75 Thousand | 91.21 Thousand | 95 Thousand | - | - | 234.07 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 46.75 Thousand | 11.25 Thousand | 16.92 Thousand | 19.19 Thousand | -1263.00 | 1395.00 |
| Inventory | - | - | - | - | - | - |
| Other working capital | 69.32 Thousand | 65.52 Thousand | 3567.00 | -17.99 Thousand | 1263.00 | 37.68 Thousand |
| Cash at beginning of period | 98.29 Thousand | 79.67 Thousand | 22.62 Thousand | 58.07 Thousand | 98.29 Thousand | 7628.00 |
| Cash at end of period | 43.41 Thousand | 43.41 Thousand | 79.67 Thousand | 22.62 Thousand | 58.07 Thousand | 98.29 Thousand |
| Capital Expenditure | - | -3.34 | - | - | - | - |
| Effect of forex changes on cash | -15.00 | -27.00 | -1.00 | -123.00 | 136.00 | -86.00 |
| Net cash flow / Change in cash | -54.88 Thousand | -36.26 Thousand | 57.05 Thousand | -35.45 Thousand | -40.22 Thousand | 90.66 Thousand |
| Free Cash Flow | -145.89 Thousand | -30.25 Thousand | -37.94 Thousand | -35.32 Thousand | -40.35 Thousand | -25.62 Thousand |
VINATIORGA
1514
4075
4904
TOT
SINDHUTRAD